These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10833913)

  • 21. Clinical venous thromboembolism following joint surgery: effect of extended thromboprophylaxis on its annual frequency and postoperative pattern over 22 years.
    Dahl OE; Gudmundsen TE; Pripp AH; Aanesen JJ
    Clin Appl Thromb Hemost; 2014 Mar; 20(2):117-23. PubMed ID: 24113492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clexane (enoxaparin) or Fragmin (dalteparin) as thrombolytics in hip surgery? Misunderstandings of the purchasing order in the municipality of Oslo].
    Brørs O
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2351-2. PubMed ID: 8804215
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevention of thromboembolism in surgery of fractures of the upper end of the femur].
    Kudrna K; Krska Z; Kvasnicka J; Bríza J; Trca S
    Sb Lek; 2002; 103(2):203-12. PubMed ID: 12688143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative start compared to preoperative start of low-molecular-weight heparin increases mortality in patients with femoral neck fractures.
    Leer-Salvesen S; Dybvik E; Dahl OE; Gjertsen JE; EngesæTer LB
    Acta Orthop; 2017 Feb; 88(1):48-54. PubMed ID: 27658532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended prophylaxis of venous thromboembolism in major orthopaedic surgery.
    Verhaeghe R
    Acta Orthop Belg; 2005 Jun; 71(3):255-9. PubMed ID: 16035696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
    Tran AH; Lee G
    Ann Pharmacother; 2003 Nov; 37(11):1632-43. PubMed ID: 14565815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of thrombosis in surgery: low molecular weight heparin/standard heparin].
    Weinand HA; Gehrke T; Krieg H; Brünner H
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1175-7. PubMed ID: 1983508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of venous thromboembolism in orthopedic surgery and traumatology].
    Agnelli G; Cimminiello C
    Recenti Prog Med; 2007 Jan; 98 Suppl 1():25S-32S. PubMed ID: 17455706
    [No Abstract]   [Full Text] [Related]  

  • 31. Venous thromboembolism following major orthopedic surgery: review of epidemiology and economics.
    Edelsberg J; Ollendorf D; Oster G
    Am J Health Syst Pharm; 2001 Nov; 58 Suppl 2():S4-13. PubMed ID: 11715837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical Practice.
    Lassen MR; Haas S; Kreutz R; Mantovani LG; Holberg G; Turpie AG
    Clin Appl Thromb Hemost; 2016 Mar; 22(2):138-46. PubMed ID: 26408640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the duration of thromboembolic prophylaxis after high-risk orthopaedic surgery: the ETHOS observational study.
    Bergqvist D; Arcelus JI; Felicissimo P;
    Thromb Haemost; 2012 Feb; 107(2):270-9. PubMed ID: 22186708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of thromboembolism in surgery].
    Reilmann H; Bosch U; Barthels M
    Orthopade; 1988 Feb; 17(1):110-7. PubMed ID: 2836777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chronicity of hypercoagulative state: a favourable evidence for postoperative prolongation of antithrombotic prophylaxis].
    Iturbe Hernández T; Cornudella Lacasa R; Moreno Chulilla JA; Gutiérrez Martín M
    Med Clin (Barc); 2003 Apr; 120(14):559. PubMed ID: 12724070
    [No Abstract]   [Full Text] [Related]  

  • 38. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
    Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
    J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
    Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trials with low molecular weight heparins in the prevention of postoperative thromboembolic complications: a meta-analysis.
    Lassen MR; Borris LC; Christiansen HM; Schøtt P; Olsen AD; Sørensen JV; Rahr H; Jensen HP
    Semin Thromb Hemost; 1991; 17 Suppl 3():284-90. PubMed ID: 1661437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.